Table 2. Summary of age specific seropositive study participants by community.
Community (years) | Age Category | N | T. cruzi seropositive n (%) | 95% Confidence Interval |
---|---|---|---|---|
Pindoc | 75 | 20 (26.7%) | 17.1–38.1% | |
<10 | 14 | 0 | 0–23.2% | |
11–20 | 19 | 0 | 0–17.7% | |
21–40 | 14 | 4 (28.6%) | 8.4–58.1% | |
>40 | 28 | 16 (57.1%) | 37.2–75.5% | |
Nuevo Guayaquil | 63 | 7 (11.1%) | 4.6–21.6% | |
<10 | 11 | 0 | 0–28.5% | |
11–20 | 16 | 1 (6.3%) | 0.2–30.2% | |
21–40 | 19 | 2 (10.5%) | 1.3–33.1% | |
>40 | 17 | 4 (23.5%) | 6.8–49.9% | |
Casa Blanca | 130 | 10 (7.7%) | 3.8–13.7% | |
<10 | 24 | 0 | 0–14.3% | |
11–20 | 35 | 2 (5.7%) | 0.70–19.2% | |
21–40 | 31 | 3 (9.7%) | 2.0–25.8% | |
>40 | 40 | 5 (12.5%) | 4.2–26.8% | |
La Esperanza | 123 | 12 (9.8%) | 5.1–16.4% | |
<10 | 32 | 0 | 0–10.9% | |
11–20 | 32 | 6 (18.8%) | 7.2–36.4% | |
21–40 | 36 | 3 (8.3%) | 1.8–22.5% | |
>40 | 23 | 3 (13.0%) | 2.8–33.6% | |
Campo Florido | 195 | 40 (20.5%) | 15.0–26.9% | |
<10 | 74 | 7 (9.5%) | 3.9–18.5% | |
11–20 | 37 | 15 (40.5%) | 24.8–57.9% | |
21–40 | 42 | 8 (19.1%) | 8.6–34.1% | |
>40 | 42 | 10 (23.8%) | 12.1–39.5% | |
Rumiaco | 25 | 2 (8.0%) | 1.0–26.0% | |
<10 | 4 | 1 (25.0%) | 0.6–80.1% | |
11–20 | 8 | 0 | 0–36.9% | |
21–40 | 7 | 1 (14.3%) | 0.4–57.9% | |
>40 | 6 | 0 | 0–45.9% |